[Federal Register Volume 74, Number 164 (Wednesday, August 26, 2009)]
[Notices]
[Pages 43140-43141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-20483]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0383]


Request for Notification From Industry Organizations Interested 
in Participating in the Selection Process for a Nonvoting Industry 
Representative on the Tobacco Products Scientific Advisory Committee 
and Request for Nominations for a Nonvoting Industry Representative on 
the Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting that any 
industry organizations interested in participating in the selection of 
a nonvoting industry representative to serve on its Tobacco Products 
Scientific Advisory Committee notify FDA in writing. A nominee may 
either be self-nominated or nominated by an organization to serve as a 
nonvoting industry representative. Nominations will be accepted for 
current vacancies effective with this notice. Elsewhere in this issue 
of the Federal Register, FDA is publishing two separate documents 
announcing the establishment of the committee and the request for 
nomination of the Tobacco Products Scientific Advisory Committee.

DATES: Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests must send a letter stating the interest to FDA by September 
25, 2009, for vacancies listed in the notice. Concurrently, nomination 
material for

[[Page 43141]]

prospective candidates should be sent to FDA by September 25, 2009.

ADDRESSES: All nominations for membership should be sent electronically 
to <a href="/cdn-cgi/l/email-protection#315247715e521f5755501f565e47"><span class="__cf_email__" data-cfemail="325144725d511c5456531c555d44">[email protected]</span></a>, or by mail to Advisory Committee Oversight & 
Management Staff, 5600 Fishers Lane (HF-4), rm. 14C03, Rockville, MD 
20857.

FOR FURTHER INFORMATION CONTACT: Erik P. Mettler, Office of Policy, 
Office of the Commissioner, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 1, rm. 4324, Silver Spring, MD 20993, 301-796-
4711, FAX: 301-847-3541, e-mail: <a href="/cdn-cgi/l/email-protection#c7a2b5aeace9aaa2b3b3aba2b587a1a3a6e9afafb4e9a0a8b1"><span class="__cf_email__" data-cfemail="dabfa8b3b1f4b7bfaeaeb6bfa89abcbebbf4b2b2a9f4bdb5ac">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The agency requests nominations for 
nonvoting industry representatives on the Tobacco Products Scientific 
Advisory Committee. Elsewhere in this issue of the Federal Register, 
FDA is publishing two separate documents announcing the establishment 
of the committee and the request for nomination of the Tobacco Products 
Scientific Advisory Committee.

I. Center for Tobacco

Tobacco Products Scientific Advisory Committee

    The Tobacco Products Scientific Advisory Committee advises the 
Commissioner or designee in discharging responsibilities as they relate 
to the regulation of tobacco products. The Committee reviews and 
evaluates safety, dependence, and health issues relating to tobacco 
products and provides appropriate advice, information, and 
recommendations to the Commissioner of Food and Drugs.
    The Committee shall include three nonvoting members who are 
identified with industry interests. These members shall include one 
representative of the tobacco manufacturing industry, one 
representative of the interests of tobacco growers, and one 
representative of the interests of the small business tobacco 
manufacturing industry. This final position can be filled on a 
rotating, sequential basis by representatives of different small 
business tobacco manufacturers based on areas of expertise relevant to 
the topics being considered by the Committee.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate nonvoting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document. Within the subsequent 30 days, FDA will send a letter to 
each organization that has expressed an interest, attaching a complete 
list of all such organizations; and a list of all nominees along with 
their current resumes. The letter will also state that it is the 
responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the nonvoting member to represent industry 
interests for the Tobacco Products Scientific Advisory Committee. The 
interested organizations are not bound by the list of nominees in 
selecting a candidate. However, if no individual is selected within 60 
days, the Commissioner of Food and Drugs will select the nonvoting 
member to represent industry interests.

III. Application Procedure

    Individuals may self nominate and/or an organization may nominate 
one or more individuals to serve as a nonvoting industry 
representative. A current curriculum vitae and the name of the 
committee of interest should be sent to the FDA contact person within 
the 30 days. FDA will forward all nominations to the organizations 
expressing interest in participating in the selection process for the 
committee. (Persons who nominate themselves as nonvoting industry 
representatives will not participate in the selection process).
    FDA has a special interest in ensuring that women, minority groups, 
individuals with physical disabilities, and small businesses are 
adequately represented on its advisory committees, and therefore, 
encourages, nominations for appropriately qualified candidates from 
these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 19, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-20483 Filed 8-25-09; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>